glp-1 cardiovascular outcomes trial results august 2025 Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials Beyond Blood Sugar: A Scoping

Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans

Effects were larger in trials enrolling participants with binge eating disorder

In some cases, compounders used non-equivalent salt forms, while others mass-produced for telehealth platforms in ways that skirted individual prescription rules

Noom defines a microdose as a dose of medication that is a fraction 25% or less of the typically prescribed maintenance dose

Discussion This study builds on our previous work demonstrating the metabolic benefits of yerba mat (YM), providing novel insights into its mechanisms of action, particularly its ability to modulate incretin levels

This is the best-established thing about it, and it is animal work